位置:首页 > 蛋白库 > SYD_THEKO
SYD_THEKO
ID   SYD_THEKO               Reviewed;         438 AA.
AC   Q52428; Q5JD76;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=Aspartate--tRNA(Asp) ligase {ECO:0000255|HAMAP-Rule:MF_02075};
DE            EC=6.1.1.12 {ECO:0000255|HAMAP-Rule:MF_02075};
DE   AltName: Full=Aspartyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02075};
DE            Short=AspRS {ECO:0000255|HAMAP-Rule:MF_02075};
DE   AltName: Full=Discriminating aspartyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02075};
DE            Short=D-AspRS {ECO:0000255|HAMAP-Rule:MF_02075};
GN   Name=aspS {ECO:0000255|HAMAP-Rule:MF_02075}; OrderedLocusNames=TK0492;
OS   Thermococcus kodakarensis (strain ATCC BAA-918 / JCM 12380 / KOD1)
OS   (Pyrococcus kodakaraensis (strain KOD1)).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Thermococcus.
OX   NCBI_TaxID=69014;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC BAA-918 / JCM 12380 / KOD1;
RX   PubMed=7590306; DOI=10.1016/0378-1119(95)00491-n;
RA   Imanaka T., Lee S., Takagi M., Fujiwara S.;
RT   "Aspartyl-tRNA synthetase of the hyperthermophilic archaeon Pyrococcus sp.
RT   KOD1 has a chimerical structure of eukaryotic and bacterial enzymes.";
RL   Gene 164:153-156(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-918 / JCM 12380 / KOD1;
RX   PubMed=15710748; DOI=10.1101/gr.3003105;
RA   Fukui T., Atomi H., Kanai T., Matsumi R., Fujiwara S., Imanaka T.;
RT   "Complete genome sequence of the hyperthermophilic archaeon Thermococcus
RT   kodakaraensis KOD1 and comparison with Pyrococcus genomes.";
RL   Genome Res. 15:352-363(2005).
RN   [3]
RP   FUNCTION AS A DISCRIMINATING ASPRS.
RX   PubMed=12149259; DOI=10.1074/jbc.m204767200;
RA   Tumbula-Hansen D., Feng L., Toogood H., Stetter K.O., Soll D.;
RT   "Evolutionary divergence of the archaeal aspartyl-tRNA synthetases into
RT   discriminating and nondiscriminating forms.";
RL   J. Biol. Chem. 277:37184-37190(2002).
RN   [4]
RP   FUNCTION AS A DISCRIMINATING ASPRS, CATALYTIC ACTIVITY, AND SUBSTRATE
RP   SPECIFICITY.
RC   STRAIN=ATCC BAA-918 / JCM 12380 / KOD1;
RX   PubMed=12660169; DOI=10.1093/emboj/cdg148;
RA   Charron C., Roy H., Blaise M., Giege R., Kern D.;
RT   "Non-discriminating and discriminating aspartyl-tRNA synthetases differ in
RT   the anticodon-binding domain.";
RL   EMBO J. 22:1632-1643(2003).
RN   [5]
RP   FUNCTION AS A DISCRIMINATING ASPRS, CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF TRP-26 AND
RP   LYS-85, AND DISCRIMINATION SITES.
RX   PubMed=12730374; DOI=10.1073/pnas.0631525100;
RA   Feng L., Tumbula-Hansen D., Toogood H., Soll D.;
RT   "Expanding tRNA recognition of a tRNA synthetase by a single amino acid
RT   change.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:5676-5681(2003).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF APOENZYME AND IN COMPLEXES WITH
RP   ATP-MG; ASPARTATE AND ASPARTYL-AMP, COFACTOR, AND SUBUNIT.
RC   STRAIN=ATCC BAA-918 / JCM 12380 / KOD1;
RX   PubMed=9724658; DOI=10.1093/emboj/17.17.5227;
RA   Schmitt E., Moulinier L., Fujiwara S., Imanaka T., Thierry J.-C., Moras D.;
RT   "Crystal structure of aspartyl-tRNA synthetase from Pyrococcus
RT   kodakaraensis KOD: archaeon specificity and catalytic mechanism of
RT   adenylate formation.";
RL   EMBO J. 17:5227-5237(1998).
CC   -!- FUNCTION: Catalyzes the attachment of L-aspartate to tRNA(Asp) in a
CC       two-step reaction: L-aspartate is first activated by ATP to form Asp-
CC       AMP and then transferred to the acceptor end of tRNA(Asp). Is specific
CC       for tRNA(Asp) since it aspartylates tRNA(Asn) 3 orders of magnitude
CC       less efficiently than tRNA(Asp). {ECO:0000269|PubMed:12149259,
CC       ECO:0000269|PubMed:12660169, ECO:0000269|PubMed:12730374}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-aspartate + tRNA(Asp) = AMP + diphosphate + L-
CC         aspartyl-tRNA(Asp); Xref=Rhea:RHEA:19649, Rhea:RHEA-COMP:9660,
CC         Rhea:RHEA-COMP:9678, ChEBI:CHEBI:29991, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:78442, ChEBI:CHEBI:78516,
CC         ChEBI:CHEBI:456215; EC=6.1.1.12; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_02075, ECO:0000269|PubMed:12660169,
CC         ECO:0000269|PubMed:12730374};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02075,
CC         ECO:0000269|PubMed:9724658};
CC       Note=Binds 3 Mg(2+) cations per subunit. The strongest magnesium site
CC       (Mg1) is bound to the beta- and gamma-phosphates of ATP and four water
CC       molecules complete its coordination sphere. {ECO:0000255|HAMAP-
CC       Rule:MF_02075, ECO:0000269|PubMed:9724658};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 uM for tRNA(Asp) (at 60 degrees Celsius)
CC         {ECO:0000269|PubMed:12730374};
CC         Note=kcat is 0.061 sec(-1) for tRNA(Asp) aspartylation (at 60 degrees
CC         Celsius).;
CC       Temperature dependence:
CC         Optimum temperature is 60 degrees Celsius.
CC         {ECO:0000269|PubMed:12730374};
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_02075,
CC       ECO:0000269|PubMed:9724658}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02075}.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family.
CC       Type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02075}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D45167; BAA08115.1; -; Genomic_DNA.
DR   EMBL; AP006878; BAD84681.1; -; Genomic_DNA.
DR   RefSeq; WP_011249447.1; NC_006624.1.
DR   PDB; 1B8A; X-ray; 1.90 A; A/B=1-438.
DR   PDB; 3NEL; X-ray; 1.95 A; A/B=1-438.
DR   PDB; 3NEM; X-ray; 1.89 A; A/B=1-438.
DR   PDB; 3NEN; X-ray; 2.40 A; A/B=1-438.
DR   PDBsum; 1B8A; -.
DR   PDBsum; 3NEL; -.
DR   PDBsum; 3NEM; -.
DR   PDBsum; 3NEN; -.
DR   AlphaFoldDB; Q52428; -.
DR   SMR; Q52428; -.
DR   STRING; 69014.TK0492; -.
DR   EnsemblBacteria; BAD84681; BAD84681; TK0492.
DR   GeneID; 3235903; -.
DR   KEGG; tko:TK0492; -.
DR   PATRIC; fig|69014.16.peg.483; -.
DR   eggNOG; arCOG00406; Archaea.
DR   HOGENOM; CLU_004553_2_1_2; -.
DR   InParanoid; Q52428; -.
DR   OMA; WVHEIRD; -.
DR   OrthoDB; 24288at2157; -.
DR   PhylomeDB; Q52428; -.
DR   BRENDA; 6.1.1.12; 5246.
DR   SABIO-RK; Q52428; -.
DR   EvolutionaryTrace; Q52428; -.
DR   Proteomes; UP000000536; Chromosome.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0004815; F:aspartate-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0006422; P:aspartyl-tRNA aminoacylation; IBA:GO_Central.
DR   Gene3D; 2.40.50.140; -; 1.
DR   Gene3D; 3.30.930.10; -; 1.
DR   HAMAP; MF_02075; Asp_tRNA_synth_type2; 1.
DR   InterPro; IPR004364; Aa-tRNA-synt_II.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL.
DR   InterPro; IPR004523; Asp-tRNA_synthase_2.
DR   InterPro; IPR002312; Asp/Asn-tRNA-synth_IIb.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR004365; NA-bd_OB_tRNA.
DR   PANTHER; PTHR43450; PTHR43450; 1.
DR   Pfam; PF00152; tRNA-synt_2; 1.
DR   Pfam; PF01336; tRNA_anti-codon; 1.
DR   PRINTS; PR01042; TRNASYNTHASP.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF55681; SSF55681; 1.
DR   TIGRFAMs; TIGR00458; aspS_nondisc; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Protein biosynthesis;
KW   Reference proteome.
FT   CHAIN           1..438
FT                   /note="Aspartate--tRNA(Asp) ligase"
FT                   /id="PRO_0000111005"
FT   REGION          192..195
FT                   /note="Aspartate"
FT   BINDING         170
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT   BINDING         214..216
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         214
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT   BINDING         222..224
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         361
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         361
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT   BINDING         361
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="3"
FT   BINDING         364
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT   BINDING         364
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT   BINDING         368
FT                   /ligand="L-aspartate"
FT                   /ligand_id="ChEBI:CHEBI:29991"
FT   BINDING         409..412
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   SITE            26
FT                   /note="Important for tRNA discrimination"
FT   SITE            85
FT                   /note="Important for tRNA discrimination"
FT   MUTAGEN         26
FT                   /note="W->H: Gains the ability to form Asp-tRNA(Asn) in
FT                   vitro. Only 2-fold decrease in catalytic efficiency for
FT                   Asp-tRNA(Asp) synthesis."
FT                   /evidence="ECO:0000269|PubMed:12730374"
FT   MUTAGEN         85
FT                   /note="K->P: Gains the ability to form Asp-tRNA(Asn) in
FT                   vitro, and is impaired in its ability to synthesize Asp-
FT                   tRNA(Asp) due to a 8-fold decrease in affinity for
FT                   tRNA(Asp)."
FT                   /evidence="ECO:0000269|PubMed:12730374"
FT   CONFLICT        413
FT                   /note="L -> V (in Ref. 1; BAA08115)"
FT                   /evidence="ECO:0000305"
FT   HELIX           7..9
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           12..14
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          18..31
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          34..41
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          44..51
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   TURN            52..54
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           57..62
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           63..65
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          71..80
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          87..99
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           117..122
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           124..127
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           131..153
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          163..167
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          172..174
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          177..180
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          183..187
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           192..197
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           198..200
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          205..213
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          225..236
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           240..261
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           263..268
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           285..294
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           307..321
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          324..330
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          344..346
FT                   /evidence="ECO:0007829|PDB:3NEN"
FT   STRAND          349..357
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          360..368
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           372..381
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           386..389
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           390..394
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          403..409
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           410..417
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   HELIX           423..426
FT                   /evidence="ECO:0007829|PDB:3NEM"
FT   STRAND          427..429
FT                   /evidence="ECO:0007829|PDB:3NEM"
SQ   SEQUENCE   438 AA;  50910 MW;  E03C8766ADD2209A CRC64;
     MYRTHYSSEI TEELNGQKVK VAGWVWEVKD LGGIKFLWIR DRDGIVQITA PKKKVDPELF
     KLIPKLRSED VVAVEGVVNF TPKAKLGFEI LPEKIVVLNR AETPLPLDPT GKVKAELDTR
     LDNRFMDLRR PEVMAIFKIR SSVFKAVRDF FHENGFIEIH TPKIIATATE GGTELFPMKY
     FEEDAFLAQS PQLYKQIMMA SGLDRVYEIA PIFRAEEHNT TRHLNEAWSI DSEMAFIEDE
     EEVMSFLERL VAHAINYVRE HNAKELDILN FELEEPKLPF PRVSYDKALE ILGDLGKEIP
     WGEDIDTEGE RLLGKYMMEN ENAPLYFLYQ YPSEAKPFYI MKYDNKPEIC RAFDLEYRGV
     EISSGGQREH RHDILVEQIK EKGLNPESFE FYLKAFRYGM PPHGGFGLGA ERLIKQMLDL
     PNIREVILFP RDRRRLTP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024